Survey of Ophthalmology
Volume 44, Supplement 2 , Pages S147-S153, January 2000

Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt®)

  • Lewis H. Silver, PhD

      Affiliations

    • Alcon Research, Ltd., Fort Worth, TX, USA
    • Corresponding Author InformationReprint address: Lewis H. Silver, PhD, Senior Director, Clinical Science, Ophthalmic Products, Alcon Laboratories, Inc., 6201 South Freeway, R5-10, Fort Worth, TX 76134-2099
    • ,
  • the Brinzolamide Dose-Response Study Group

      Affiliations

    • Alcon Research, Ltd., Fort Worth, TX, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0039-6257(99)00110-1

Survey of Ophthalmology
Volume 44, Supplement 2 , Pages S147-S153, January 2000

Article Tools